2 results
Approved WMOPending
To assess the efficacy of treatment with sulodexide for chronic heart failure.
Approved WMORecruiting
To assess the effect of donanemab versus placebo on clinical progression in participants with early symptomatic AD with demonstrated presence of low-medium tau pathology.